Institute of Molecular Pathology

The Research Institute of Molecular Pathology (IMP) is a premier basic biomedical research center located at the Vienna BioCenter in Austria. Founded in 1985 and primarily funded by the pharmaceutical company Boehringer Ingelheim, the IMP conducts fundamental research in the molecular life sciences. Its research clusters include molecular and cellular biology, neurobiology, and disease mechanisms, with a strong emphasis on understanding the fundamental processes of life. While the IMP does not develop commercial products or clinical assets directly, its discoveries often provide the mechanistic basis for drug development programs within Boehringer Ingelheim. The institute is globally recognized for its high-impact scientific publications and its role as a training ground for international scientific talent. It maintains state-of-the-art facilities for cryo-electron microscopy, proteomics, and bioinformatics to support its diverse research groups.